ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.320
-0.020 (-1.49%)
At close: May 13, 2025, 4:00 PM
1.470
+0.150 (11.36%)
Pre-market: May 14, 2025, 9:02 AM EDT
ADC Therapeutics Employees
As of December 31, 2024, ADC Therapeutics had 265 total employees, including 263 full-time and 2 part-time employees. The number of employees decreased by 9 or -3.28% compared to the previous year.
Employees
265
Change (1Y)
-9
Growth (1Y)
-3.28%
Revenue / Employee
$267,309
Profits / Employee
-$595,645
Market Cap
130.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265 | -9 | -3.28% |
| Dec 31, 2023 | 274 | -43 | -13.56% |
| Dec 31, 2022 | 317 | 5 | 1.60% |
| Dec 31, 2021 | 312 | 104 | 50.00% |
| Dec 31, 2020 | 208 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ADCT News
- 1 hour ago - ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - PRNewsWire
- 1 hour ago - ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML) - PRNewsWire
- 6 days ago - ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 - PRNewsWire
- 16 days ago - ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025 - PRNewsWire
- 6 weeks ago - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - PRNewsWire
- 6 weeks ago - ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 6 weeks ago - ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update - PRNewsWire